Tag: infectious diseases

Pfizer and BioNTech raised questions last week with news of a plan to seek authorization for COVID booster shots and to develop a new Delta variant COVID vaccine. Our experts answer those questions.

New research shows that people nursing homes with higher concentrations of Black and Latino residents were more than 50% more likely to be infected with COVID and twice as likely to die in the first ...

URMC is participating in a new clinical trial that will help inform public health decisions around re-vaccination schedules and the deployment of boosters that target COVID variants.

Wastewater monitoring is a promising tool for COVID-19 surveillance, according to a new paper published in the International Journal of Environmental Public Health. Researchers from the University of ...

URMC neurologist Gretchen Birbeck, M.D., M.P.H., has received a $4.3 million award from the NIH to continue her research in sub-Saharan Africa on the neurological problems that arise in people ...

Infectious disease experts Mary Caserta, M.D., and Jennifer Nayak, M.D., and pediatrician Elizabeth Murray, D.O., discuss why the COVID pediatric vaccine is effective, thoroughly tested and safe for ...

The past year has challenged URMC in ways no one could have imagined. There’s no denying the Rochester-strong courage, tenacity, and teamwork that got us through an unforgettable year.

Learn why experts agree that the benefits of the Johnson and Johnson vaccine greatly outweigh its risks. This vaccine can reach vulnerable populations more easily than other vaccines.

It’s too soon to know with certainty, but experience with other infectious diseases leads experts to believe that your immune system will probably be able to detect and respond to the coronavirus for ...

You may have heard that the J&J Covid vaccine isn’t as effective as others, but what "effective" means is largely misunderstood. Two experts explain what you need to know about the new vaccine.